Projects per year
Personal profile
Research interests
My main research interest is in the political economy of the pharmaceutical industry. I critically examine pharmaceutical companies' financial interactions with healthcare organisations and patient organisations, their legislative and executive lobbying activities, and assess how the self-regulatory approach to pharmaceutical industry transparency works in practice.
Education/Academic qualification
Social Policy, Doctor of Philosophy, The pharmaceutical industry's web of influence in the UK
1 Oct 2018 → 13 Dec 2024
Award Date: 13 Dec 2024
Sociology, Master of Research, University of Bath
3 Oct 2016 → 2 Oct 2018
Award Date: 2 Oct 2018
Sociology, Bachelor of Science, University of Bath
3 Oct 2011 → 3 Jul 2015
Award Date: 3 Jul 2015
Fingerprint
Dive into the research topics where Emily Rickard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Political economy of the UK pharmaceutical industry in an age of uncertainty and volatility
Rickard, E. (PI), Lancaster, K. (CoI) & Ozieranski, P. (CoI)
1/10/25 → 30/09/26
Project: Research council
-
Volatile relationships: pharmaceutical industry funding and the politics of patient advocacy
Rickard, E. (PI) & Ozieranski, P. (CoI)
Foundation for the Sociology of Health and Illness
21/10/26 → 20/10/27
Project: UK charity
-
ESRC IAA - Closing the Gaps: Policy Reform for Transparency in UK Healthcare.
Rickard, E. (PI) & Ozieranski, P. (CoI)
1/08/25 → 30/09/25
Project: Research council
-
ESRC IAA - Transparency impact
Ozieranski, P. (PI) & Rickard, E. (Researcher)
1/02/25 → 31/08/25
Project: Research council
-
Evaluating conflict-of-interest governance among Canadian medical societies using a novel assessment tool: A cross-sectional study
Rickard, E. & Lexchin, J., 14 May 2026, In: PLoS ONE. 21, 5, 11 p., e0348311.Research output: Contribution to journal › Article › peer-review
Open Access -
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation
Ozieranski, P., Rickard, E. & Mulinari, S., 7 Jan 2025, (E-pub ahead of print) In: BMJ Evidence-Based Medicine. 6 p., bmjebm-2024-113101.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (SciVal) -
Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019: A content analysis
Larkin, J., Matthes, B., Azribi, M., Kearns, C., Mulinari, S., Rickard, E., Moriarty, F., Fahey, T. & Ozieranski, P., 30 Nov 2024, In: Health Policy. 149, 105155.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Citations (SciVal) -
IPR Policy Brief: Protecting patients and the NHS through full transparency in industry-NHS collaborations
Ozieranski, P., Larkin, J., Rickard, E., Mulinari, S., Ozaki, A., MacLeod, R. & Sansom, K., Oct 2024Research output: Book/Report › Commissioned report
Open Access -
Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
Rickard, E., Carmel, E. & Ozieranski, P., 29 Mar 2023, In: BMJ Open. 13, 3, e061591.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Citations (SciVal)
Datasets
-
Data set for "A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups"
Rickard, E. (Creator) & Ozieranski, P. (Creator), University of Bath, 28 May 2021
DOI: 10.15125/BATH-00943
Dataset
-
Dataset for "A patient-industry complex? Investigating the financial dependency of UK patient organisations on drug company funding"
Ozieranski, P. (Creator), Pitter, J. (Creator), Rickard, E. (Creator), Mulinari, S. (Creator) & Csanadi, M. (Creator), University of Bath, 7 Dec 2021
DOI: 10.15125/BATH-00904
Dataset
-
Underreporting of drug industry payments to patient organisations in the UK (2012-2016)
Ozieranski, P. (Creator), Csanadi, M. (Creator), Rickard, E. (Creator) & Mulinari, S. (Creator), University of Bath, 10 Jul 2020
DOI: 10.15125/BATH-00784
Dataset
-
Dataset for "Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis"
Rickard, E. (Creator) & Ozieranski, P. (Creator), University of Bath, 29 Mar 2023
DOI: 10.15125/BATH-01239
Dataset
Thesis
-
The pharmaceutical industry’s web of influence in the UK
Rickard, E. (Author), Carmel, E. (Supervisor), Ozieranski, P. (Supervisor) & Tchilingirian, J. (Supervisor), 11 Dec 2024Student thesis: Doctoral Thesis › PhD
File
Activities
-
Rapid Technology Assessment on GLP-1 receptor agonists
Rickard, E. (Contributor)
11 Dec 2025Activity: Knowledge Exchange (Industry, Government, NGOs) › Stakeholder engagement, presentation
-
AUTH/3876/2/24 - Complainants v Novo Nordisk Allegations about disclosure of transfers of value
Rickard, E. (No value), Ozieranski, P. (No value) & Mulinari, S. (No value)
2025Activity: Knowledge Exchange (Industry, Government, NGOs) › Giving evidence or preparing policy briefs
-
A prescription for transparency: Reforming industry payments in UK healthcare
Ozieranski, P. (No value) & Rickard, E. (No value)
2025Activity: Media article or participation, blog › Blog
-
"Sunshine legislation for the UK: Learning from international best practice"
Rickard, E. (Speaker) & Ozieranski, P. (Speaker)
6 May 2025Activity: Knowledge Exchange (Industry, Government, NGOs) › Stakeholder engagement, presentation
-
Panel: "Can Self-Regulation Survive Scrutiny?"
Rickard, E. (Speaker) & Ozieranski, P. (Speaker)
5 Nov 2025Activity: Knowledge Exchange (Industry, Government, NGOs) › Stakeholder engagement, presentation